Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > The Journal of Cardiovascular Surgery 2010 April;51(2) > The Journal of Cardiovascular Surgery 2010 April;51(2):157-68

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE JOURNAL OF CARDIOVASCULAR SURGERY

Rivista di Chirurgia Cardiaca, Vascolare e Toracica


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,179


eTOC

 

REVIEWS  ADVANCES IN THORACIC ENDOGRAFTING


The Journal of Cardiovascular Surgery 2010 April;51(2):157-68

Copyright © 2010 EDIZIONI MINERVA MEDICA

lingua: Inglese

Comparison of CE approved TEVAR devices

Gawenda M., Brunkwall J.

Department of Vascular Surgery, University of Cologne, Cologne, Germany


PDF  


The indications for endovascular therapy of thoracic aortic pathologies are expanding. The complexity of cases is increasing. The individual anatomy and pathology of the thoracic aorta alone and in combination create specific difficulties in stent graft delivery, deployment, and fixation. Graft design has evolved, and several new iterations of stent grafts have been introduced into clinical practice. The assessment of these new grafts is difficult, due to the changing indications for their use and a lack of large-scale clinical trials. Currently, a number of thoracic stent graft devices are available in Europe. Variable amounts of clinical data are available to support their use.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

michael.gawenda@uk-koeln.de